The European Medicines Agency review of ipilimumab (Yervoy) for the treatment of advanced (unresectable or metastatic) melanoma in adults who have received prior therapy: Summary of the scientific assessment of the Committee for Medicinal Products for Human Use-Reference-Cited by-同舟云学术

The European Medicines Agency review of ipilimumab (Yervoy) for the treatment of advanced (unresectable or metastatic) melanoma in adults who have received prior therapy: Summary of the scientific assessment of the Committee for Medicinal Products for Human Use

Published:2012-01 Issue:2 Volume:48 Page:237-242
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Hanaizi Zahra,van Zwieten-Boot Barbara,Calvo Gonzalo,Lopez Arantxa Sancho,van Dartel Maaike,Camarero Jorge,Abadie Eric,Pignatti Francesco

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference9 articles.

1. Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group;Bedikian;J Clin Oncol,2006

2. Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma;Chapman;J Clin Oncol,1999

3. Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma;Middleton;J Clin Oncol,2000

4. Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: a meta-analysis of 3273 patients from 20 randomized trials;Huncharek;Melanoma Res,2001

5. Interferons in melanoma;Agarwala;Curr Opin Oncol,1996

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming Resistance to Immune Checkpoint Blockade in Liver Cancer with Combination Therapy: Stronger Together?;Seminars in Liver Disease;2024-05

2. Immune checkpoint inhibitors in metastatic melanoma therapy (Review);Medicine International;2024-02-09

3. Immunotherapy around the Clock: Impact of Infusion Timing on Stage IV Melanoma Outcomes;Cells;2023-08-15

4. Rutin Inhibits Hepatic and Pancreatic Cancer Cell Proliferation by Inhibiting CYP3A4 and GST;Indian Journal of Pharmaceutical Education and Research;2023-06-05

5. Regulatory landscape in the approval of cancer vaccine;Nanotherapeutics in Cancer Vaccination and Challenges;2022